Tesamorelin 20mg Vial Dosage Guide
What Tesamorelin Is
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates the pituitary gland to release the body’s natural growth hormone.
In clinical studies, Tesamorelin has been researched for reducing visceral abdominal fat and improving metabolic markers, particularly in individuals with metabolic complications.
Rather than supplying growth hormone directly, Tesamorelin signals the body to produce its own, helping maintain natural hormone rhythms.
Reconstitution:
• Add 4.0 mL bacteriostatic water → final concentration 5.0 mg/mL
• This concentration keeps dosing math consistent across vial sizes
Typical Daily Dose Range
• 0.5–2 mg once daily (gradual escalation recommended)
• Conservative escalation → 0.5 mg → 1 mg → 1.5 mg → 2 mg
• Clinical trials most commonly used 2 mg daily
Syringe Math
• At 5.0 mg/mL → 1 unit = 0.01 mL ≈ 50 mcg on a U-100 insulin syringe
Storage
Lyophilized (freeze-dried):
• Freeze at −20 °C (−4 °F)
Reconstituted:
• Refrigerate at 2–8 °C (35.6–46.4 °F)
• Use within 2–4 weeks
Daily Dosing Schedule
Phase | Daily Dose | Syringe Units | Volume |
Weeks 1–2 | 500 mcg (0.5 mg) | 10 units | 0.10 mL |
Weeks 3–4 | 1,000 mcg (1 mg) | 20 units | 0.20 mL |
Weeks 5–6 | 1,500 mcg (1.5 mg) | 30 units | 0.30 mL |
Week 7+ | 2,000 mcg (2 mg) | 40 units | 0.40 mL |
Frequency: Once daily, subcutaneous.
Timing: Often administered before bedtime to align with natural growth hormone release patterns.
How to Reconstitute (Step-by-Step)
Draw 4.0 mL bacteriostatic water
Inject slowly down the vial wall (prevents foaming)
Gently swirl or roll — never shake
Label with reconstitution date
Refrigerate (2–8 °C) and protect from light
Why 4.0 mL?
Using 4.0 mL keeps the same 5 mg/mL concentration as the 10 mg vial, so syringe math stays identical across vial sizes.
This makes dosing simpler and easier to remember.
Supply Planning
Tesamorelin 20 mg Vials
• 4-week protocol: ~1 vial
• 12-week protocol: ~3–4 vials
• 24-week protocol: ~7–8 vials
Syringes
• 1 per day
• 4 weeks: 28
• 12 weeks: 84
• 24 weeks: 168
Bacteriostatic Water (4 mL per vial)
• 4 weeks: ~4 mL
• 12 weeks: ~16 mL
• 24 weeks: ~32 mL
Alcohol Pads
• 2 per injection
• 4 weeks: 56
• 12 weeks: 168
• 24 weeks: 336
Protocol Overview
Goal
Support reduction of visceral abdominal fat, improved metabolic markers, and optimized growth hormone signaling.
Structure
• Once-daily injections
• Gradual escalation → 0.5 mg → 1 mg → 1.5 mg → 2 mg
• Clinical trials commonly used 2 mg daily
Reconstitution
4.0 mL → 5.0 mg/mL for simple dosing math across vial sizes.
Storage
Freeze lyophilized; refrigerate reconstituted solution.
Storage Instructions (Keep It Potent)
Lyophilized
• Store frozen at −20 °C or colder
• Protect from moisture and light
Reconstituted
• Refrigerate at 2–8 °C
• Use within 2–4 weeks
Handling Tips
• Let frozen vials reach room temperature before opening
• Avoid heat or direct sunlight
• Minimize freeze–thaw cycles
• Aliquot if storing long-term
Important Practical Notes
• Stay consistent — inject at the same time each day
• Evening injections are common due to natural nighttime GH release
• Use a new sterile syringe every time
• Rotate injection sites (abdomen, thighs, upper arms)
• Start lower (0.5–1 mg) if sensitivity occurs
How Tesamorelin Works
Tesamorelin stimulates growth hormone release from the pituitary gland, which increases IGF-1 levels that regulate metabolism and fat utilization.
Growth hormone signaling supports:
Fat metabolism and fat breakdown
Lean body composition
Tissue recovery and metabolic function
In clinical studies:
Tesamorelin significantly reduced visceral abdominal fat
Participants showed improvements in lipid markers and waist circumference
Long-term studies demonstrated sustained reductions in trunk fat mass
Benefits & Side Effects
Potential Benefits
• Reduction in visceral abdominal fat
• Improved metabolic markers
• Support for natural growth hormone production
• Daily dosing allows steady hormone signaling
Common Side Effects
• Mild water retention or swelling
• Joint stiffness or muscle discomfort
• Injection site redness or irritation
• Temporary tingling sensations
Most side effects reported in studies were mild and manageable.
Disclaimer:
All peptide products sold on this website are for research, laboratory, and educational purposes only. They are not approved by the FDA or Health Canada, are not intended for human consumption, and should not be used for medical, cosmetic, or therapeutic purposes unless specifically prescribed by a licensed healthcare professional.
The information provided on this site is for informational and educational purposes only and does not constitute medical advice. Product descriptions, protocols, or references are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new protocol, supplement, or treatment.
By purchasing from this website, you acknowledge and agree to use these products responsibly and in accordance with all applicable laws and guidelines.